JDRF Blog

Latest in Prevention

  • A Team in Boston Trying to Prevent Type 1 Diabetes

    October 29, 2019

    JDRF is funding work on multiple ways to delay or prevent the onset of type 1 diabetes (T1D). This team thinks fat...

  • Can Two Viral Drugs Halt Type 1 Diabetes?

    October 17, 2019

    Scientists in Norway are seeking participants for a clinical trial to see if a course of anti-viral treatment may stop beta cell...

  • FDA Breakthrough Therapy Designation for Teplizumab—Based on the First Study to Delay the Onset of T1D for 2+ Years

    August 5, 2019

    The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to teplizumab, an anti-CD3 monoclonal antibody, for the prevention or delay...

  • ADA Scientific Sessions Recap—Day #3.5: Jessica Dunne, Ph.D.

    June 10, 2019

    There was some really exciting prevention research in day #3, and also screening for type 1 diabetes risk. Here is Jessica Dunne,...

  • First Human Study to Significantly Delay—by Two Years!—Type 1 Diabetes Onset

    June 9, 2019

    This is big. No, wait, this is ENORMOUSLY HUGE. Published today in the New England Journal of Medicine, an immunotherapy demonstrated a...

  • Multiple Benefits of Screening For Beta Cell Autoimmunity in Children

    February 19, 2019

    Normally, our immune system ignores our body’s own safe cells and attacks only dangerous foreign cells. But our bodies create autoantibodies—antibodies against...

  • T1D Diagnosis? Gut Bacteria May Hold the Clue

    February 14, 2019

    Over the past 50 years, type 1 diabetes (T1D) has increased significantly in many developed countries around the world. There is a...

  • JDRF Leads Push to Develop a Vaccine for Viral Infections that Could Trigger T1D

    January 31, 2019

    Scientists worldwide are attempting to determine why some people predisposed to type 1 diabetes (T1D) eventually end up developing the disease. There...

  • JDRF Drives Next-Generation Type 1 Diabetes Research With New Partnerships & Breakthrough Science

    December 22, 2018

    JDRF, the leading global organization funding type 1 diabetes (T1D) research, announced today that it made progressive advances this year on its...